- Home
- ONL vs EPIX Comparison
ONL vs EPIX Comparison
Compare ONL & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONL
- EPIX
- Stock Information
- Founded
- ONL 2021
- EPIX 2009
- Country
- ONL United States
- EPIX Canada
- Employees
- ONL N/A
- EPIX N/A
- Industry
- ONL Real Estate Investment Trusts
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- ONL Real Estate
- EPIX Health Care
- Exchange
- ONL Nasdaq
- EPIX Nasdaq
- Market Cap
- ONL 226.6M
- EPIX 209.4M
- IPO Year
- ONL N/A
- EPIX N/A
- Fundamental
- Price
- ONL $4.01
- EPIX $1.76
- Analyst Decision
- ONL Hold
- EPIX Hold
- Analyst Count
- ONL 1
- EPIX 4
- Target Price
- ONL N/A
- EPIX $9.50
- AVG Volume (30 Days)
- ONL 252.5K
- EPIX 2.4M
- Earning Date
- ONL 11-07-2024
- EPIX 12-10-2024
- Dividend Yield
- ONL 9.97%
- EPIX N/A
- EPS Growth
- ONL N/A
- EPIX N/A
- EPS
- ONL N/A
- EPIX N/A
- Revenue
- ONL $169,644,000.00
- EPIX N/A
- Revenue This Year
- ONL N/A
- EPIX N/A
- Revenue Next Year
- ONL N/A
- EPIX N/A
- P/E Ratio
- ONL N/A
- EPIX N/A
- Revenue Growth
- ONL N/A
- EPIX N/A
- 52 Week Low
- ONL $3.01
- EPIX $1.40
- 52 Week High
- ONL $6.22
- EPIX $11.67
- Technical
- Relative Strength Index (RSI)
- ONL 54.63
- EPIX 24.56
- Support Level
- ONL $3.75
- EPIX $1.66
- Resistance Level
- ONL $3.91
- EPIX $1.89
- Average True Range (ATR)
- ONL 0.15
- EPIX 0.12
- MACD
- ONL 0.01
- EPIX 0.05
- Stochastic Oscillator
- ONL 71.76
- EPIX 62.86
About ONL Orion Office REIT Inc.
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.